*ST大药
(603963)
| 流通市值：2.59亿 | | | 总市值：2.59亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 188,634,309.59 | 207,687,516.43 | 139,404,998.81 | 39,680,747.92 |
| 应收票据及应收账款 | 11,189,544.23 | 7,667,788.2 | 1,750,452.27 | 1,807,386.74 |
| 其中：应收票据 | - | - | 43,020 | - |
| 应收账款 | 11,189,544.23 | 7,667,788.2 | 1,707,432.27 | 1,807,386.74 |
| 预付款项 | 791,383.12 | 1,939,227 | 328,362 | 410,430.37 |
| 其他应收款合计 | 32,840.9 | 162,388.61 | 156,939.65 | 171,873.32 |
| 存货 | 53,625,817.28 | 55,759,990.34 | 60,143,881.27 | 61,029,039.1 |
| 其他流动资产 | 373,364.45 | 87,162.59 | 289.91 | 35,088.8 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 254,647,259.57 | 273,304,073.17 | 282,566,875.01 | 278,867,887.21 |
| 非流动资产: | | | | |
| 投资性房地产 | 60,022,774.01 | 60,478,367.48 | 60,933,960.95 | 61,389,554.42 |
| 固定资产 | 75,797,846.25 | 76,894,440.73 | 78,155,566.62 | 79,073,452.66 |
| 在建工程 | - | - | - | 682,886 |
| 使用权资产 | 1,083,056.16 | 1,286,129.19 | 1,489,202.22 | 1,692,275.25 |
| 无形资产 | 33,892,090.47 | 34,161,590.55 | 34,416,538.03 | 34,684,858.18 |
| 递延所得税资产 | 124,739.39 | 3,907,961.54 | 4,318,729.07 | 4,936,774.01 |
| 其他非流动资产 | 99,400 | 171,000 | 63,840 | 9,100 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 171,019,906.28 | 176,899,489.49 | 179,377,836.89 | 182,468,900.52 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 425,667,165.85 | 450,203,562.66 | 461,944,711.9 | 461,336,787.73 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 10,348,279.74 | 11,455,224.57 | 10,296,718.9 | 10,036,869.56 |
| 应付账款 | 10,348,279.74 | 11,455,224.57 | 10,296,718.9 | 10,036,869.56 |
| 预收款项 | 419,517.86 | 993,468.83 | 1,332,976.77 | 643,909.58 |
| 合同负债 | 22,161,117.97 | 26,426,526.86 | 27,894,046.57 | 13,802,990.06 |
| 应付职工薪酬 | 217,016.38 | 115,016.38 | 125,267.02 | 836,972.81 |
| 应交税费 | 1,459,304.64 | 1,282,934.16 | 1,438,657.69 | 820,992.47 |
| 其他应付款合计 | 27,869,554.06 | 27,741,382.91 | 29,240,769.11 | 35,034,341.26 |
| 一年内到期的非流动负债 | 13,847,129.29 | 8,831,536.21 | 8,823,063.34 | 8,827,197.51 |
| 其他流动负债 | 436,734.6 | 488,554.22 | 1,962,176.92 | 43,276.29 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 76,758,654.54 | 77,334,644.14 | 81,113,676.32 | 70,046,549.54 |
| 非流动负债: | | | | |
| 长期借款 | 1,001,114.59 | 10,511,971.87 | 10,512,084.37 | 14,020,339.26 |
| 租赁负债 | - | 493,614.14 | 705,163.05 | 831,595.96 |
| 递延收益 | 258,500.24 | 280,500.23 | 302,500.22 | 324,500.21 |
| 递延所得税负债 | 162,458.42 | 192,919.38 | 340,673 | 363,839.43 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,422,073.25 | 11,479,005.62 | 11,860,420.64 | 15,540,274.86 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 78,180,727.79 | 88,813,649.76 | 92,974,096.96 | 85,586,824.4 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 219,700,000 | 219,700,000 | 219,700,000 | 219,700,000 |
| 资本公积 | 117,799,200 | 117,799,200 | 117,799,200 | 117,799,200 |
| 盈余公积 | 32,668,913.13 | 32,668,913.13 | 32,668,913.13 | 32,668,913.13 |
| 未分配利润 | -22,681,675.07 | -8,778,200.23 | -1,197,498.19 | 5,581,850.2 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 347,486,438.06 | 361,389,912.9 | 368,970,614.94 | 375,749,963.33 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 347,486,438.06 | 361,389,912.9 | 368,970,614.94 | 375,749,963.33 |
| 负债和股东权益合计 | 425,667,165.85 | 450,203,562.66 | 461,944,711.9 | 461,336,787.73 |
| 公告日期 | 2025-04-25 | 2024-10-31 | 2024-08-30 | 2024-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |